DE69625682D1 - Verfahren zur behandlung von entzündungen und zusammensetzungen dafür - Google Patents
Verfahren zur behandlung von entzündungen und zusammensetzungen dafürInfo
- Publication number
- DE69625682D1 DE69625682D1 DE69625682T DE69625682T DE69625682D1 DE 69625682 D1 DE69625682 D1 DE 69625682D1 DE 69625682 T DE69625682 T DE 69625682T DE 69625682 T DE69625682 T DE 69625682T DE 69625682 D1 DE69625682 D1 DE 69625682D1
- Authority
- DE
- Germany
- Prior art keywords
- treating
- serp
- compositions
- ignitions
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 101710181917 Serine proteinase inhibitor 1 Proteins 0.000 abstract 3
- 230000006378 damage Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000008595 infiltration Effects 0.000 abstract 1
- 238000001764 infiltration Methods 0.000 abstract 1
- 210000004969 inflammatory cell Anatomy 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Manufacture And Refinement Of Metals (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/411,043 US5939525A (en) | 1995-03-27 | 1995-03-27 | Methods of treating inflammation and compositions therefor |
| PCT/US1996/004054 WO1996030042A2 (en) | 1995-03-27 | 1996-03-26 | Methods of treating inflammation and compositions therefor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69625682D1 true DE69625682D1 (de) | 2003-02-13 |
| DE69625682T2 DE69625682T2 (de) | 2003-10-02 |
Family
ID=23627329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69625682T Expired - Lifetime DE69625682T2 (de) | 1995-03-27 | 1996-03-26 | Verfahren zur behandlung von entzündungen und zusammensetzungen dafür |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5939525A (de) |
| EP (1) | EP0817646B1 (de) |
| JP (1) | JPH11503122A (de) |
| AT (1) | ATE230609T1 (de) |
| AU (1) | AU5323396A (de) |
| CA (1) | CA2214988A1 (de) |
| DE (1) | DE69625682T2 (de) |
| DK (1) | DK0817646T3 (de) |
| ES (1) | ES2187646T3 (de) |
| PT (1) | PT817646E (de) |
| WO (1) | WO1996030042A2 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPP508798A0 (en) * | 1998-08-05 | 1998-08-27 | Biotech Australia Pty Limited | Method of treating psoriasis |
| JP2003512436A (ja) * | 1999-10-27 | 2003-04-02 | アレクサンドラ ルーカス、 | 移植片拒絶を防止及び治療するための組成物及び方法 |
| AU1943501A (en) * | 1999-12-02 | 2001-06-12 | Viron Therapeutics, Inc. | Methods of treating inflammation and compositions therefor |
| US20040029244A1 (en) * | 2000-05-25 | 2004-02-12 | Ben-Tsion Williger | Phospholipase d effectors for therapy and screening |
| WO2002026245A2 (en) * | 2000-09-29 | 2002-04-04 | Zhong Z Robert | Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions |
| JP2004528010A (ja) | 2000-10-11 | 2004-09-16 | バイロン・セラピューティックス・インコーポレーテッド | 免疫モジュレーションのための核酸およびポリペプチド |
| EP1339737B1 (de) * | 2000-12-04 | 2007-06-13 | Viron Therapeutics, Inc. | Proteine aus yaba monkey tumor virus mit modulatorischer aktivität |
| US7718368B2 (en) * | 2000-12-04 | 2010-05-18 | Viron Therapeutics Inc. | Immunomodulatory protein and useful embodiments thereof |
| WO2002070473A2 (en) * | 2001-03-05 | 2002-09-12 | Transtech Pharma, Inc. | Carboxamide derivatives as therapeutic agents |
| US20030083305A1 (en) * | 2001-10-10 | 2003-05-01 | Peter Palese | Viral interferon antagonists and uses therefor |
| GB0125594D0 (en) * | 2001-10-25 | 2001-12-19 | Univ Sheffield | Inhibitors for inactivating allergens |
| AU2003280252A1 (en) * | 2002-11-01 | 2004-05-25 | Alexandra R. Lucas | Viral serpin regulation of inflamation |
| US7285530B2 (en) * | 2004-10-21 | 2007-10-23 | Viron Therapeutics, Inc. | Use of SERP-1 as an antiplatelet agent |
| US8251876B2 (en) | 2008-04-22 | 2012-08-28 | Hill-Rom Services, Inc. | Breathing exercise apparatus |
| US9180271B2 (en) | 2012-03-05 | 2015-11-10 | Hill-Rom Services Pte. Ltd. | Respiratory therapy device having standard and oscillatory PEP with nebulizer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5206017A (en) * | 1986-06-03 | 1993-04-27 | Incyte Pharmaceuticals, Inc. | Use of protease nexin-I as an antiinflammatory |
| DE69123960T2 (de) * | 1990-10-16 | 1997-05-07 | John Lezdey | Behandlung von entzündungen |
| WO1992022320A1 (en) * | 1991-06-14 | 1992-12-23 | Genentech, Inc. | C1 inhibitor variants and treating inflammatory response with c1 inhibitor |
| DE4214215A1 (de) * | 1992-04-30 | 1993-11-04 | Behringwerke Ag | Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen |
| EP0754054B1 (de) * | 1994-04-08 | 2002-07-03 | Viron Therapeutics, Inc. | Antirestenoses protein |
-
1995
- 1995-03-27 US US08/411,043 patent/US5939525A/en not_active Expired - Fee Related
- 1995-06-06 US US08/468,865 patent/US5917014A/en not_active Expired - Lifetime
-
1996
- 1996-03-26 DE DE69625682T patent/DE69625682T2/de not_active Expired - Lifetime
- 1996-03-26 DK DK96909862T patent/DK0817646T3/da active
- 1996-03-26 ES ES96909862T patent/ES2187646T3/es not_active Expired - Lifetime
- 1996-03-26 CA CA002214988A patent/CA2214988A1/en not_active Abandoned
- 1996-03-26 EP EP96909862A patent/EP0817646B1/de not_active Expired - Lifetime
- 1996-03-26 AT AT96909862T patent/ATE230609T1/de not_active IP Right Cessation
- 1996-03-26 PT PT96909862T patent/PT817646E/pt unknown
- 1996-03-26 JP JP8529572A patent/JPH11503122A/ja active Pending
- 1996-03-26 WO PCT/US1996/004054 patent/WO1996030042A2/en active IP Right Grant
- 1996-03-26 AU AU53233/96A patent/AU5323396A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11503122A (ja) | 1999-03-23 |
| PT817646E (pt) | 2003-04-30 |
| US5939525A (en) | 1999-08-17 |
| US5917014A (en) | 1999-06-29 |
| WO1996030042A3 (en) | 1996-11-21 |
| EP0817646B1 (de) | 2003-01-08 |
| DK0817646T3 (da) | 2003-04-22 |
| WO1996030042A2 (en) | 1996-10-03 |
| ATE230609T1 (de) | 2003-01-15 |
| ES2187646T3 (es) | 2003-06-16 |
| AU5323396A (en) | 1996-10-16 |
| DE69625682T2 (de) | 2003-10-02 |
| EP0817646A2 (de) | 1998-01-14 |
| CA2214988A1 (en) | 1996-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69625682D1 (de) | Verfahren zur behandlung von entzündungen und zusammensetzungen dafür | |
| DE69733132D1 (de) | Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen | |
| ES2166783T3 (es) | Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii. | |
| DE69535264D1 (de) | Verfahren zur behandlung von diabetes mittels kgf | |
| DE69826695D1 (de) | Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen | |
| DE69027865D1 (de) | ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN | |
| IS4083A (is) | Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja | |
| EP1007556A4 (de) | Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese | |
| DE69835823D1 (de) | Verfahren zur behandlung von patienten die unter multipler sklerose leiden mit konsensus-interferon | |
| DE69703689D1 (de) | Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia | |
| ATE453402T1 (de) | Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis | |
| SE9603725D0 (sv) | New teatment | |
| IS5101A (is) | Aðferðir við inngjöf efnasambanda sem eru mótefnigegn CD40L í sambandi við læknismeðferð | |
| EA199700241A1 (ru) | Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран | |
| ATE321045T1 (de) | Methoden und zusammensetzungen zur behandlung von schmerzen | |
| ATE251462T1 (de) | Verfahren zur behandlung von narbengewebe | |
| DE69623316D1 (de) | Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen | |
| HUP9903679A2 (hu) | Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására | |
| DE69729201T2 (de) | Sulfonfluoride zur behandlung von der alzheimerischen krankheit | |
| DE69829995D1 (de) | Multivalente rekombinante antikörper zur behandlung von hrv infektionen | |
| ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
| ATE295731T1 (de) | Olanzapine zur behandlung von drogenmissbrauch | |
| NO984198L (no) | FremgangsmÕte for behandling av aggresjon | |
| ATE318612T1 (de) | Methoden und zusammensetzungen zur behandlung der hyperlipidämie | |
| ATE280584T1 (de) | Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |